The drug resistance-related protein LRP is the human major vault protein

Nature Medicine

Volumn 1, Issue 6, 1995, Pages 578-582

  Scheffer, George L ^a   Wijngaard, Peter L J ^b   Flens, Marcel J ^a   Izquierdo, Miguel A ^a   Slovak, Marilyn L ^c   Pinedo, Herbert M ^a   Meijer, Chris J L M ^a   Clevers, Hans C ^b   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG RESISTANCE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CHROMOSOME 16; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMAL; CHROMOSOMES, HUMAN, PAIR 16; COMPARATIVE STUDY; DNA, COMPLEMENTARY; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMAN; IN SITU HYBRIDIZATION, FLUORESCENCE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; ORGANELLES; RATS; RIBONUCLEOPROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0029048485     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0695-578     Document Type: Article

References (33)

1. Roninson, I.B. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells (Plenum, New York, 1991).
2. Endicott, J.A. & Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Amu. Rev. Biochem. 58, 137-171 (1989).
3. Cole, S.P.C. et al. Overexpression of a transporter gene in a multidrug- resistant human lung cancer cell line. Science 258, 1650-1654 (1992).
4. Zaman, G.J.R. et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. natn. Acad. Sci. U.S.A. 91, 8822-8826 (1994).
5. Futscher, B.W., Abbaszadegan, M.R., Domann, F. & Dalton, W.S. Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. Biochem. Pharmacol 47, 1601-1606 (1994).
6. Takeda, Y. et al. Reversal of multidug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line. Int. J. Cancer 57, 229-239 (1994).
7. Slapak, C.A. et al. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin selected multidrug- resistant murine erythroleukemia cells. Cancer Res. 54, 5607-5613 (1994).
8. Scheper, RJ. et al. Overexpression of a Af(r) 110, 000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 53, 1475-1479 (1993).
9. List, A.F. et al. Non-P-glycoprotein (Pgp) mediated multidrug resistance (MDR): Identification of a novel drug resistance phenotype with prognostic relevance in acute myeloid leukemia (AML). Blood 82, (suppl. 1) 443a (1993).
10. Izquierdo, M.A. et al. Prognostic significance of the drug resistance associated protein LRP in advanced ovarian carcinoma. Ann. Oncol. 5, (suppl. 8), 98 (1994).
11. Kickhoefer, V.A. & Rome, L.H. The sequence of a cDNA encoding the major vault protein from Rattus norvegicus. Gene 151, 257-260 (1994).
12. Vasu, S.K., Kedersha, N.L. & Rome, L.H. cDNA cloning and disruption of the major vault protein alpha gene (mvpA) in Dictyostelium discoideum. J. biol. Chem. 268, 15356-15360 (1993).
13. Kedersha, N.L. & Rome, L.H. Isolation and characterization of a novel ri- bonucleoprotein particle: Large structures contain a single species of small RNA. J. cell Biol 103, 699-709 (1986).
14. Rome, L.H., Kedersha, N.L. & Chugani, D.C. Unlocking vaults: Organelles in search of a function. Trends Cell Biol. 1, 47 (1991).
15. Kedersha, N.L., Miquel, M.C., Bittner, D. & Rome, L.H. Vaults II. Ribonucle- oprotein structures are highly conserved among higher and lower eukaryotes. J. cell Biol. 110, 895-901 (1990).
16. Wu, L. et al. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res. 52, 3029-3034 (1992).
17. Slovak, M.L. et al. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res. 53, 3221-3225 (1993).
18. Francke, U., Yang Feng, T.L., Brissenden, J.E. & Ullrich, A. Chromosomal mapping of genes involved in growth control. Cold Spring Harb. Symp. quant Biol. 51, 855-866 (1986).
19. Chambers, T.C., Zheng, B. & Kuo, J.F. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Molec. Pharmacol. 41, 1008-1015 (1992).
20. Kuss, B.J. et al Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: Prognostic implications. Lancet 343, 1531-1534 (1994).
21. Chugani, D.C., Rome, L.H. & Kedersha, N.L. Evidence that vault ribonucleo- protein particles localize to the nuclear pore complex. J. cell Sci. 106, 23-29 (1993).
22. Rout, M.P. & Wente S.R. Pores for thought: Nuclear pore complex proteins. Trends cell Biol 4, 357-365 (1994).
23. Schuurhuis, GJ. et al Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br. J. Cancer 64, 857-861 (1991).
24. Dietel, M., Arps, H., Lage, H. & Niendorf, A. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res. 50, 6100-6106 (1990).
25. Slovak, M.L., Hoeltge, G.A., Dalton, W.S. & Trent, J.M. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Cancer Res. 48, 2793-2797 (1988).
26. Zijlstra, J.G., de Vries, E.G.E. & Mulder, N.H. Multifactorial drug resistance in an Adriamycin-resistant human small-cell lung carcinoma cell line. Cancer Res. 47, 1780-1784 (1987).
27. Kuiper, C.M. et al Drug transport variants without P-glycoprotein overexpression from a human squamous lung cancer cell line after selection with doxorubicin. J. Cell Pharm. 1, 35-41 (1990).
28. Eva, A. et al. Cellular genes analogous to retroviral one genes are transcribed in human tumour cells. Nature 295, 116 (1982).
29. Muller, W.J., Naujokas, M.A. & Hassell, J.A. Isolation of large T antigen- producing cell lines capable of supporting replication of polyomavirusplasmid recombinants. Molec. cell. Biol. 4, 2406-2412 (1984).
30. Wijngaard, P.L.J., Metzelaar, M.J., McHugh, N.D., Morrison, W.I, & Clevers, H.C. Molecular characterization of the WC1 antigen expressed specifically on bovine CD4- CD8- gamma delta T lymphocytes. J. Immun. 149, 3273-3277 (1992).
31. Aruffo, A. & Seed, B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. natn. Acad. Sci. U.S.A. 84, 8573-8577 (1987).
32. Sanger, F., Nicklen, S. & Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proc. natn. Acad. Sci. U.S.A. 74, 5463-5467 (1977).
33. Zinn, K., Dimaio, D. & Maniatis, T. Identification of two distinct regulatory regions adjacent to the human beta-interferon gene. Cell 34, 865-879 (1983).